What are the various brand names for Dicloxacillin combination medications. How many brands are currently available in the market. Which pharmaceutical companies manufacture these generic versions.

Overview of Dicloxacillin Combination Medications

Dicloxacillin is a widely used antibiotic that often comes in combination with other medications. This comprehensive guide explores the various brand names, combinations, and manufacturers of Dicloxacillin-based products available in the market. With 62 different brands listed, healthcare professionals and patients have a wide array of options to choose from based on specific needs and availability.

Understanding Dicloxacillin and Its Combinations

Dicloxacillin belongs to the penicillin group of antibiotics and is primarily used to treat bacterial infections. It’s often combined with other antibiotics or beneficial bacteria to enhance its effectiveness or reduce side effects. Common combinations include:

• Dicloxacillin + Amoxycillin
• Dicloxacillin + Ampicillin
• Dicloxacillin + Cefixime
• Dicloxacillin + Amoxycillin + Lactobacillus Sporegens

These combinations can offer broader spectrum coverage against various bacterial strains or provide additional benefits such as improved gut health.

Top Manufacturers of Dicloxacillin Combination Drugs

Several pharmaceutical companies produce generic versions of Dicloxacillin combinations. Some of the prominent manufacturers include:

1. Centaur Pharmaceuticals Pvt Ltd
2. Hetero Healthcare Ltd.
3. Piramal Healthcare
4. Kee Pharma Ltd.
5. Alna Biotech

These companies have established themselves as reliable producers of high-quality generic medications, making Dicloxacillin combinations more accessible and affordable for patients worldwide.

Popular Dicloxacillin Brand Names and Their Compositions

Among the 62 brand names listed, some stand out due to their unique compositions or widespread availability. Here are a few notable examples:

1. Abcloxx

Manufactured by Centaur Pharmaceuticals Pvt Ltd, Abcloxx contains Amoxycillin (250mg) + Dicloxacillin (250mg). This combination provides broad-spectrum coverage against both gram-positive and gram-negative bacteria.

2. Baxin D LB+

Produced by Hetero Healthcare Ltd., this medication combines Dicloxacillin, Amoxycillin, and Lacto Bacillus Sporegens. The addition of probiotics may help reduce antibiotic-associated side effects.

3. Asert D

Piramal Healthcare’s Asert D combines Dicloxacillin with Cefixime, potentially offering enhanced coverage against certain resistant bacterial strains.

Dosage Forms and Administration Routes

Dicloxacillin combination medications come in various forms to suit different patient needs and treatment protocols. Common dosage forms include:

• Tablets
• Capsules
• Syrups
• Creams
• Gels
• Ointments
• Liquids
• Injections

The availability of multiple administration routes allows healthcare providers to tailor treatment plans to individual patient requirements, considering factors such as age, severity of infection, and patient preferences.

Pricing and Accessibility of Dicloxacillin Combinations

The cost of Dicloxacillin combination medications can vary significantly based on factors such as brand name, dosage strength, and package size. To get accurate pricing information, it’s recommended to consult with local pharmacies or healthcare providers. Many online platforms also offer price comparison tools for these medications.

Do generic versions of Dicloxacillin combinations offer cost savings compared to brand-name products? Generally, generic medications tend to be more affordable than their brand-name counterparts while maintaining the same efficacy and safety profiles. This can make treatment more accessible to a broader range of patients.

Regulatory Approval and Quality Assurance

All Dicloxacillin combination medications must undergo rigorous testing and approval processes before entering the market. Regulatory bodies such as the FDA in the United States or equivalent organizations in other countries ensure that these drugs meet strict quality and safety standards.

How often are new Dicloxacillin combinations approved? The approval of new combinations or formulations depends on various factors, including clinical need, research findings, and regulatory requirements. Pharmaceutical companies continually work on developing improved formulations to address evolving healthcare needs.

Choosing the Right Dicloxacillin Combination

Selecting the most appropriate Dicloxacillin combination medication depends on several factors:

• Type and severity of the infection
• Patient’s age and overall health
• Potential drug interactions
• Local antibiotic resistance patterns
• Cost and availability

Healthcare providers consider these factors when prescribing Dicloxacillin combinations to ensure optimal treatment outcomes. It’s crucial for patients to follow their doctor’s recommendations and complete the full course of antibiotics as prescribed.

Can patients switch between different Dicloxacillin combination brands? While the active ingredients may be similar, it’s essential to consult with a healthcare provider before switching brands. Differences in inactive ingredients or slight variations in drug ratios could potentially affect treatment efficacy or side effects.

Potential Side Effects and Precautions

Like all medications, Dicloxacillin combinations can cause side effects in some patients. Common side effects may include:

• Gastrointestinal disturbances (nausea, diarrhea)
• Skin rashes
• Allergic reactions (in penicillin-sensitive individuals)

It’s important for patients to be aware of these potential side effects and report any unusual symptoms to their healthcare provider promptly. Additionally, certain precautions should be taken when using Dicloxacillin combinations:

1. Inform your doctor about any known allergies, especially to penicillin or cephalosporin antibiotics.
2. Disclose all current medications, including over-the-counter drugs and supplements, to avoid potential interactions.
3. Follow the prescribed dosage and duration of treatment carefully to prevent antibiotic resistance.
4. Avoid alcohol consumption during the treatment period, as it may interfere with the medication’s effectiveness.

Are there any specific patient groups that should exercise extra caution when using Dicloxacillin combinations? Pregnant women, nursing mothers, elderly patients, and those with kidney or liver problems should consult their healthcare provider before starting treatment with these medications. Dosage adjustments or alternative treatments may be necessary in some cases.

Future Developments in Dicloxacillin Combination Therapies

The field of antibiotic research is continuously evolving, and new developments in Dicloxacillin combination therapies are likely to emerge. Some potential areas of advancement include:

• Novel drug combinations to combat resistant bacterial strains
• Improved formulations for enhanced bioavailability and reduced side effects
• Development of extended-release versions for more convenient dosing schedules
• Integration of Dicloxacillin combinations with cutting-edge drug delivery systems

These advancements aim to enhance the efficacy of Dicloxacillin-based treatments while minimizing potential drawbacks such as antibiotic resistance and side effects.

How might future research impact the availability and use of Dicloxacillin combinations? As our understanding of bacterial infections and antibiotic resistance grows, we may see more targeted and personalized approaches to antibiotic therapy. This could lead to the development of new Dicloxacillin combinations tailored to specific pathogens or patient populations.

Global Availability and Market Trends

The availability of Dicloxacillin combination medications can vary significantly across different countries and regions. Factors influencing global availability include:

• Local regulatory requirements
• Prevalence of specific bacterial infections
• Healthcare system structure and policies
• Economic factors affecting drug pricing and distribution

Market trends suggest a growing demand for broad-spectrum antibiotics like Dicloxacillin combinations, particularly in regions with high rates of bacterial infections or limited access to healthcare services.

Are there significant differences in Dicloxacillin combination usage between developed and developing countries? Developing countries may rely more heavily on broad-spectrum antibiotic combinations due to limited diagnostic capabilities and higher infection rates. However, this trend also raises concerns about the potential for increased antibiotic resistance in these regions.

Patient Education and Responsible Use

Promoting responsible use of Dicloxacillin combinations is crucial for maintaining their effectiveness and minimizing the risk of antibiotic resistance. Key aspects of patient education include:

1. Understanding the importance of completing the full course of antibiotics
2. Recognizing when antibiotics are necessary and when they’re not (e.g., viral infections)
3. Proper storage and disposal of medications
4. Awareness of potential side effects and when to seek medical attention

Healthcare providers play a vital role in educating patients about the appropriate use of Dicloxacillin combinations and the broader implications of antibiotic use on public health.

How can patients contribute to the fight against antibiotic resistance? By following prescribed treatment regimens, avoiding self-medication with antibiotics, and practicing good hygiene to prevent the spread of infections, patients can play an active role in preserving the effectiveness of antibiotics like Dicloxacillin combinations.

Comparative Analysis of Dicloxacillin Combinations

When considering the various Dicloxacillin combinations available, it’s helpful to compare their features and benefits. Some key points of comparison include:

• Spectrum of activity against different bacterial strains
• Potential for synergistic effects between combined drugs
• Pharmacokinetic properties (absorption, distribution, metabolism, and excretion)
• Frequency and severity of side effects
• Cost-effectiveness and accessibility

Healthcare providers often weigh these factors when selecting the most appropriate Dicloxacillin combination for a given clinical situation.

Which Dicloxacillin combination is most effective for treating skin and soft tissue infections? While the choice depends on various factors, combinations of Dicloxacillin with Amoxicillin are often preferred for skin and soft tissue infections due to their broad coverage of common pathogens. However, local antibiotic resistance patterns should always be considered when making treatment decisions.

The Role of Dicloxacillin Combinations in Antimicrobial Stewardship

Antimicrobial stewardship programs aim to optimize the use of antibiotics, including Dicloxacillin combinations, to improve patient outcomes and reduce the development of antibiotic resistance. Key elements of these programs include:

1. Implementing evidence-based prescribing guidelines
2. Monitoring antibiotic use and resistance patterns
3. Providing ongoing education for healthcare providers and patients
4. Promoting the use of narrow-spectrum antibiotics when appropriate

By incorporating Dicloxacillin combinations into comprehensive antimicrobial stewardship strategies, healthcare systems can work towards more sustainable and effective antibiotic use.

How do antimicrobial stewardship programs impact the prescribing patterns of Dicloxacillin combinations? These programs often lead to more judicious use of broad-spectrum antibiotics like Dicloxacillin combinations, reserving them for cases where they are truly necessary. This approach helps preserve the effectiveness of these important medications for future use.

Emerging Research and Clinical Trials

Ongoing research and clinical trials continue to explore new applications and formulations of Dicloxacillin combinations. Some areas of current interest include:

• Combination therapies for multidrug-resistant bacterial infections
• Novel drug delivery systems to enhance the efficacy of Dicloxacillin combinations
• Investigating the potential of Dicloxacillin combinations in treating biofilm-associated infections
• Exploring the use of Dicloxacillin combinations in specific patient populations (e.g., pediatric or geriatric patients)

These research efforts aim to expand our understanding of Dicloxacillin combinations and uncover new ways to maximize their therapeutic potential.

What role do pharmacogenomics play in optimizing Dicloxacillin combination therapy? Emerging research in pharmacogenomics is exploring how individual genetic variations can affect a patient’s response to antibiotics. This field holds promise for personalizing Dicloxacillin combination treatments based on a patient’s genetic profile, potentially improving efficacy and reducing adverse effects.

Environmental Impact and Sustainability Considerations

The production and use of antibiotics, including Dicloxacillin combinations, can have environmental implications. Some key considerations include:

1. Antibiotic residues in wastewater and their impact on aquatic ecosystems
2. The carbon footprint associated with drug manufacturing and distribution
3. Proper disposal methods for unused or expired medications
4. The potential for antibiotic resistance development in environmental bacteria

As awareness of these issues grows, pharmaceutical companies and healthcare systems are increasingly focused on developing more sustainable practices in antibiotic production and use.

How can the environmental impact of Dicloxacillin combination production be minimized? Strategies may include implementing green chemistry principles in drug synthesis, optimizing manufacturing processes to reduce waste and energy consumption, and developing more environmentally friendly packaging materials. Additionally, improving prescription practices to reduce overuse can help minimize the environmental burden of these medications.

Pricing for 62 Dicloxacillin combination Brands

Details about the Dicloxacillin combination medication include its price and various forms, such as tablets, capsules, syrups, creams, gels, ointments, liquids, or injections.

Click on the brand name to view the drug’s price. One or more pharmaceutical companies may produce generic Dicloxacillin combination. 62 Brands are currently listed in the drug directory on Medindia that market generic versions of Dicloxacillin combination under various brand names. Our database is constantly being updated as new generics and brands receive authorization from the drug regulatory authorities and start to appear in pharmacies.

SNo	Brand Name	Combination Generics	Manufacturers	Price
1	Abcloxx	Amoxycillin (250mg) + Dicloxacillin (250mg)	Centaur Pharmaceuticals Pvt Ltd	View Price
2	ADC (250mg/ 250mg)	Ampicillin 250mg + Diclocillin 250mg	Rass Health Care	View Price
3	Alnaclox LB	Dicloxacillin, Amoxycillin, Lactobacillus Sporegens	Alna Biotech	View Price
4	Amclox-DL (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Active HC	View Price
5	Amsat (250mg/ 250mg)	Ampicillin 250mg + Diclocillin 250mg	Vensat Bio	View Price
6	Asert D	Dicloxacillin, Cefixime	Piramal Healthcare	View Price
7	Baxin D LB+	Dicloxacillin, Amoxycillin, Lacto Bacillus Sporegens	Hetero Healthcare Ltd.	View Price
8	Baxin-D (250mg/ 250mg)	Ampicillin 250mg + Diclocillin 250mg	Hetero Healthcare Ltd.	View Price
9	Baxin-D-LB (250mg/ 250mg/ 60 Million cells)	Ampicillin 250mg + Diclocillin 250mg + Lactobacillus Spogenes 60million cells	Hetero Healthcare Ltd.	View Price
10	Baxin-D-LB+ (250mg/ 250mg/ 250Million Cells)	Amoxicillin 250mg + Dicloxacillin 250mg +Lactobacillus Sporogenes 250 Million cells	Hetero Healthcare Ltd.	View Price
11	Bicidal Plus	Dicloxacillin, Amoxycillin, Lacto Bacillus Sporegens	Kee Pharma Ltd.	View Price
Advertisement
12	Blox-DC (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Blubell Pharma	View Price
13	Blumox-DXL (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Blue Cross Laboratories Ltd.	View Price
14	Calmox (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Biomiicron Pharma India Pvt. Ltd.	View Price
15	Canetax Plus (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Little Greave Pharmaceuticals Pvt. Ltd.	View Price
16	Castrov-D (200mg/ 500mg)	Cefixime Trihydrate 200mg + Dicloxacillin 500mg	Aden Healthcare	View Price
17	Cefcon D (200+500)	Dicloxacillin, Cefixime	Iscon Life Sciences	View Price
Advertisement
18	Cefex-DCL (200mg/ 250mg)	Cefixime 200mg + Dicloxacillin 250mg	Talent Healthcare	View Price
19	Cefex-DXT (200mg/ 500mg)	Cefixime 200mg + Dicloxacillin 500mg	Talent Healthcare	View Price
20	Cefikos-DX (200mg/ 500mg)	Cefixime 200mg + Dicloxacillin 500mg	Elkos Healthcare Pvt. Ltd.	View Price
21	Ceflox (200+500mg)	Dicloxacillin, Cefixime	Welkind Pharma	View Price
22	Cefocef DXL 200	Dicloxacillin, Cefixime, Lacto Bacillus Sporegens	Centaur Pharmaceuticals Pvt. Ltd.	View Price
23	Cefupop XL	Dicloxacillin, Cefixime	Alna Biotech	View Price
24	Clancef-D (200mg/ 500mg)	Cefixime Trihydrate 200mg + Dicloxacillin 500mg	Edward Young Labs	View Price
25	Cloxipen	Dicloxacillin, Amoxicillin Trihydrate, Lactic Acid Bacillus	Bestochem Formulations (India) Ltd.	View Price
26	Clynox (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Micro Labs Ltd (Eros)	View Price
27	Crinux-D (200mg/ 500mg)	Cefixime Trihydarte 200mg + Dicloxacillin 500mg	Pax Healthcare	View Price
28	Dixomox (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Intra Labs India Pvt. Ltd. (Intra Life)	View Price
29	Edomox-C (125mg/ 125mg)	Amoxicillin 125mg + Dicloxacillin 125mg	Medopharm	View Price
30	Edomox-C (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Medopharm	View Price
31	Epicillin-D (250mg/ 250mg)	Ampicillin 250mg + Diclocillin 250mg	Epitome Life Sciences	View Price
32	Epiclox-DC (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Epitome Life Sciences	View Price
33	Ethiclox – LB	Dicloxacillin, Amoxycillin, Lactobacillus Sporegens	Ethix Health Care	View Price
34	Flemiklox-DX (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	FDC Limited	View Price
35	Forclox (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Wonder Products (Forrit)	View Price
36	Formic XL	Dicloxacillin, Cefixime, Lacto Bacillus Sporegens	Elder Pharmaceuticals Pvt. Ltd.	View Price
37	Hclox (250mg/ 250mg)	Ampicillin Trihydrate 250mg + Diclocillin 250mg	Madhav BiotechPvt. Ltd.	View Price
38	Hifen LXX	Dicloxacillin, Cefixime, Lacto Bacillus Sporegens	Hetero Healthcare Ltd.	View Price
39	Inloxy-LB KID (125mg/ 125mg)	Amoxicillin 125mg + Dicloxacillin 125mg	Intra Labs India Pvt. Ltd.	View Price
40	Inloxy-SLB (250mg/ 250mg/ 15mg)	Amoxicillin 250mg + Dicloxacillin 250mg + Serrapeptase 15mg	Intra Labs India Pvt. Ltd.	View Price
41	Klox-D (250mg)	Dicloxacillin 250mg	Hetero Healthcare Ltd.	View Price
42	Klox-D (500mg)	Dicloxacillin 500mg	Hetero Healthcare Ltd.	View Price
43	Labocef-DC	Dicloxacillin, Cefixime	Laborate Pharmaceuticals India Ltd. (Multicure)	View Price
44	Lupidiclox (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Lupin Laboratories Ltd.	View Price
45	Mario-D (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Aden Healthcare	View Price
46	Moxifit-DC (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Uniflex	View Price
47	Moxpil-DC (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Progressive Life Care	View Price
48	Nomixime-D (200mg/ 500mg)	Cefixime Trihydarte 200mg + Dicloxacillin 500mg	Acinom Healthcare	View Price
49	Novaclox (125mg/ 125mg)	Amoxicillin 125mg + Dicloxacillin 125mg	Cipla Limited	View Price
50	Novaclox (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Cipla Limited	View Price
51	Novaclox (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Cipla Limited	View Price
52	Nugen XL	Dicloxacillin, Amoxycillin, Lactic Acid Bacillus	Ankare Pharmaceuticals	View Price
53	Nugen-XL (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Ankare	View Price
54	Odimox DL	Dicloxacillin, Amoxycillin, Lactobacillus Sporegens	Solitaire Pharmacia Pvt. Ltd. (CureMax)	View Price
55	Rasclox (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Rass Health Care	View Price
56	Ricomox Plus (250mg/ 250mg)	Amoxicillin 250mg + Dicloxacillin 250mg	Rishab Health Care Pvt. Ltd. (Orochem)	View Price
57	TDS LB	Dicloxacillin, Amoxycillin, Lactic Acid Bacillus	Monad Pharmaceuticals	View Price
58	Tresmox-LBD (250mg/ 250mg/ 2. 5 Billion Cells)	Amoxicillin 250mg + Dicloxacillin 250mg + Lactobacillus Sporogenes 2.5 Billion Cells	AHPL	View Price
59	Tricef-XL (200mg/ 500mg/ 60Million cells)	Cefixime 200mg + Dicloxacillin 500mg + Lactobacillus Sporogenes 60 Million cells	Wockhardt Limited (Orion)	View Price
60	Zedocef-DXL (200mg/ 500mg)	Cefpodoxime Proxetil 200mg + Dicloxacillin 500mg	Macleods Pharmaceuticals Ltd. (Oxalis)	View Price
61	Zifi-LBX (100+500)	Dicloxacillin, Cefixime, Lactobacillus Sporegens	FDC Limited (Spectra)	View Price
62	Zifi-LBX Plus 200 Tablet MR	Dicloxacillin, Cefixime, Lactobacillus Sporegens	FDC Ltd	View Price

Dicloxacillin

Dicloxacillin

Penicillin (penicillinase-resistant penicillin)

Staphylococcus spp. , Streptococcal spp.

Exerts bactericidal activity via inhibition of bacterial
cell wall synthesis by binding one or more of the penicillin binding proteins (PBPs). 
Exerts bacterial autolytic effect by inhibition of certain PBPs related to the
activation of a bacterial autolytic process. 

Penicillins
produce time-dependent killing

Cmax: 10-17mcg/ml; Oral bioavailability: 37%; Half-life:
0.8 hours; Table 6

Hematologic:  agranulocytosis, eosinophilia, hemolytic
anemia, neutropenia, inhibition of platelet aggregation

Renal:  interstitial nephritis

CNS:  seizures

Other:  Jarisch-Herxheimer Reaction (fever, chills,
sweating, tachycardia, hyperventilation, flushing, and myalgia)

Adults: 125-250 mg po q6h

Pediatric:   > 1 month and < 40 kg: 12.5 – 25 mg/kg/day po in 4 divided doses

40 kg: usual adult dose

Staphylococcal osteomyelitis:
50-100 mg/kg/day in 4 divided doses

Disease state based dosing:

Renal failure:  not necessary

Contraindications/Warnings/Precautions:

Contraindications:  Anaphylaxis to dicloxacillin or other
penicillins

Precautions:  Cephalosporin hypersensitivity

Dicloxacillin is an inducer of the cytochrome P450 3A4
isoenzyme.    Caution should be exercised and monitoring is suggested when
concomitantly administering dicloxacillin with drugs that have narrow
therapeutic windows and are substrates of the CYP3A4 enzyme.

Contraceptives – decreased contraceptive effectiveness

Live Typhoid
Vaccine – decreased immunological response to the typhoid
vaccine

Probenecid – increased dicloxacillin levels

Warfarin – decreased anticoagulant effectiveness

Pregnancy:

Category B: No evidence of risk in humans
but studies inadequate.

Monitoring Requirements:

Therapeutic: 
Culture and sensitivities, signs and symptoms of infection

Toxic:  Periodic
CBC, urinalysis, BUN, Creatinine, AST and ALT

Brand names/Manufacturer:

• AMCIDIL (Macrophar –
  THAILAND)
• AMPICLOX-D (Sanfer –
  MEXICO)
• AMPIPLUS (Menarini – ITALY)
• BRISPEN (Bristol-Myers
  Squibb  – MEXICO)
• CILPEN (Antibioticos –
  MEXICO)
• CLOMICIN (IQFA – MEXICO)
• CLOXIL (Ofimex – MEXICO)
• CLOXIPEN (Welfer – MEXICO)
• CLOXYDIN (Biomedis –
  THAILAND)
• DIAMPLICIL (Pharmacia –
  ITALY)
• DICHLOR-STAPENOR (Bayer –
  GERMANY)
• DICIL (Chemil – ITALY)
• DICILLIN (Durascan –
  DENMARK)
• DICLEX (Meiji – THAILAND)
• DICLOCIL (Bristol-Myers
  Squibb SWEDEN, NORWAY, AUSTRALIA, DENMARK, PORTUGAL, THAILAND, FINLAND, NEW
  ZEALAND, GREECE, FRANCE, NETHERLANDS, BELGIUM, HONG KONG)
• DICLOCILLIN (TO-Chemicals
  THAILAND, ITALY)
• DICLO (FIRMA – ITALY)
• DICLOSON (Unison  –
  THAILAND)
• DICLO-TECNO (Tecnofarma –
  MEXICO)
• DICLOXACILLIN (Sandoz –
  U. S.)
• DICLOXACILLIN SODIUM (Teva 
  – USA)
• DICLOXAN (IBI  – ITALY)
• DICLOX (PP Lab – THAILAND)
• DICLOXIA (Asian Pharm –
  THAILAND)
• DICLOXIN (Olan-Kemed –
  THAILAND)
• DICLOXMAN (T Man –
  THAILAND)
• DICLOXNO (Milano –
  THAILAND)
• DICLOXSIG (Sigma –
  AUSTRALIA)
• DIFLOR (Coli – ITALY)
• DILOXIN (Pond’s – THAILAND)
• DIPXAPEN (Liferpal –
  MEXICO)
• DISTAPH (Alphapharm –
  AUSTRALIA)
• DITTEROLINA (Fustery –
  MEXICO)
• DITUM (TNP – THAILAND)
• DIXEN (Maver – MEXICO)
• DIXOCILLIN (Siam Bheasach –
  THAILAND)
• DOROX (M & H  – THAILAND)
• DUPLAMOX (ISF  – ITALY)
• DUPLEXCILLINA (Metapharma –
  ITALY)
• DUPLEXIL (Eurofarmaco –
  ITALY)
• DYCILL (GlaxoSmithKline –
  USA)
• DYCILL (SmithKline Beecham
  – USA)
• DYNAPEN – (Bristol Myers
  USA, CANADA)
• DYNAPEN (Apothecon – USA)
• DYNEPEN (Bristol Myers –
  USA)
• INFECTOSTAPH (Infectopharm
  – GERMANY)
• NOVAPEN (IBP – ITALY)
• PANAC (Bristol-Myers –
  MEXICO)
• PANAC K (Bristol-Myers –
  MEXICO)
• PATHOCIL (WYETH – USA)
• PENCLOX (Pisa – MEXICO)
• PENTIDIX (Maver – MEXICO)
• POSIPEN (Sanfer – MEXICO)
• SERVIDICLOX (Biochemie –
  THAILAND)
• TOTOCILLIN (Bayer GERMANY
  – AUSTRIA)
• VELAMOX D (GlaxoSmithKline
  – ITALY)

Dicloxacillin |

This page does not exist! Do you know an interesting fact about the drug Dicloxacillin Where can you study to be a pharmacist? It is desirable in absentia. 1. pharmacists are not trained in absentia…only hospitals… there is no eyelet. 3. Medical Institute 4. In Krasnodar! In KubGMU!:) 5. Second higher education: Perm State Pharmaceutical Academy. http://www.psfa.ruI’m also going 🙂 If you have any questions, please write … How can I help !!! 9no. Trade names such as Name: Berlipril 5 Registration date: ~ Cancellation date: ~ Name: Bifosyn INN: Bifonazole Registration date: 06/02/2003 Manufacturer: Sintez AKO OAO Country: Russia Cancellation date: 06/03/2008 Name: Insulong INN: Insulin-zinc [porcine] crystalline suspension Registration date: 11/16/1987 Manufacturer: Pliva JSC Country: Yugoslavia Cancellation date: 05. 02.2008 Name: Yodantipyrine INN: Iodophenazone Registration date: 08/13/1996 Manufacturer: ~ Country: Russia Cancellation date: ~ Name: Viburnum bark INN: viburnum bark Registration date: 11/12/1970 Manufacturer: Siberian Medicines CJSC Country: Russia Cancellation date: 02/14/2007 Name: Camphor ointment 10% INN: Camphor Registration date: 03/10/1971 Manufacturer: Tula pharmaceutical factory GUP Country: Russia Cancellation date: 02/14/2007 Name: Oxaliplatin-Phylaxis INN: Oxaliplatin Registration date: 02. 02.2009 Manufacturer: Phylaxis S.A. Laboratory Country: Argentina Packer: ZiO-Zdorovye CJSC Country: Russia Cancellation date: ~ Name: DiaGen-GAS 9 Streptococcus DNA Detection Test System by Polymerase Chain Reaction0015 instant payday loan INN: Diagnosis of streptococcal infections Registration date: 06/14/2000 Manufacturer: ~ Country: Russia Cancellation date: ~ Name: Vomiting chilibukha Registration date: 04/17/2002 Manufacturer: Homeopathic medical and social center LLC Country: Russia Cancellation date: 06/26/2008 Anecdote on the topic Dicloxacillin Returning from the maternity hospital, Miss Smith first scolded and then beat her husband, pointing out that their newborn did not have the slightest resemblance to her, but was strikingly similar to her husband’s secretary Dicloxacillin – instructions for use Dicloxacillin Instruction: Pharmacological action Indications Contraindications With care Pregnancy and breastfeeding Dosage and Administration Classification Pharmacological action Dicloxacillin is a narrow-spectrum antibiotic belonging to the penicillin class. It is used to treat infections caused by susceptible Gram-positive bacteria. Active against beta-lactamase producing organisms such as Staphylococcus aureus which are resistant to most penicillins. Indications Infections of the skin and subcutaneous tissue, pneumonia, osteomyelitis caused by strains of staphylococci that form beta-lactamase. Contraindications Hypersensitivity to dicloxacillin and penicillins Precautions Lactation. Pregnancy and lactation Pregnancy FDA fetal category B. There are no adequate and well-controlled studies on the safety of dicloxacillin during pregnancy. Animal studies showed no evidence of fetal toxicity. Dicloxacillin should be used during pregnancy only if the potential benefit to the mother outweighs the potential risk to the fetus. Use during breastfeeding It is not known whether dicloxacillin passes into human breast milk. Side effects are unlikely in infants. Caution is advised when prescribing to lactating women. Dosage and administration Inside. Children < 40 kg: 12.5–50 mg/kg/day in 4 divided doses; with osteomyelitis - 50-100 mg / kg / day in 4 doses. Children over 40 kg and adults: 125-500 mg 4 times a day. Classification ATX J01CF01 Pharmacological groups Antibiotics Penicillins FDA pregnancy category B (no risk in non-human studies) Share this page More on the topic Find out more about the active substance Dicloxacillin: INN Reviews Questions Latin name Chemical formula Information about the active substance Dicloxacillin is intended for medical and pharmaceutical professionals, for reference purposes only. Leave a Reply Cancel reply Your email address will not be published. Required fields are marked * Comment * Name * Email * Website